Resumo
Estrogens and progestogens are hormones produced by maternal organs and it is required for recognition and maintenance of pregnancy. In addition, the embryo may also be a source. For this, the aim was to identify steroidogenic expression on Galea spixii embryos early in the embryonic period. Embryos were collected on Days 10 and 15 of gestation; some were fixed in 4% paraformaldehyde for morphological and immunohistochemical analysis (P450arom), whereas others had RNA extracted to determine presence of CYP19a1 gene. In addition, for immunochemistry, maternal ovaries were collected as positive control tissues. Maternal tissues had positive staining for aromatase, whereas none of the embryos stained for P450 aromatase. Based on qPCR reactions, CYP19a1 gene were expressed in all embryos. Galea spixii embryos expressed steroidogenic genes during the post-implantation period, indicating they have the potential to produce steroid hormones.(AU)
Assuntos
Animais , Feminino , Roedores/embriologia , Hormônios Esteroides Gonadais/efeitos adversos , Aromatase/químicaResumo
Background: Testicular neoplasms in dogs are more frequent than in other animal species, representing the most common tumors in elderly subjects after skin neoplasms. In cryptorchid subjects, the risk of neoplastic degeneration is high. The cytological examination is essential to differentiate the type of neoplasia and to determinate the best diagnostic approach. Aim of this report was to describe clinical and histopathological features of a dog with coexistence of Sertoli cell and interstitial endocrine cell tumors in a non-cryptorchid dog. Case: A 9-year-old non-neutered male dog, German Spitz breed, was presented to the veterinary clinic. On clinical examination, the dog had a body condition (BCS 6/9), pink mucous membranes, capillary refill time (CRT) < 2 sec, lymph nodes of normal size, afebrile, normal heart and respiratory rate. The abdomen was depressible to palpation, without pain, the skin appeared hyperpigmented, with generalized presence of comedones, pendular foreskin and absence of hair at the abdominal level, in the ventral portion of the trunk and neck, scant hair also at the level of the inner thighs and in perianal. At ultrasounds examinations, the right testicle presented a hypoechoic circular focal lesion, in the caudal pole, of 0.7 cm in diameter, well defined, echogenicity and a remnant of normal echostructure, smooth and regular margins; the left testicle showed an increase in size, irregular margins, with a heterogeneous echo structure, given by hypoechoic areas, referred to cysts, hemorrhagic or necrotic areas. The hemogram reported slightly microcytic and normochromic regenerative anemia. The leukogram showed monocytosis. The absence of the typical stress leukogram characterized by neutrophilia, lymphopenia and eosinopenia, and the reduction of ALP allows to rule out Cushing's disease. In order to rule out hypothyroidism due to the inhibitory effect of estrogens on the release of thyroid-stimulating hormone (TSH) the concentration of total thyroxine was analyzed, reporting normal values excluding hypothyroidism. Blood oestradiol 17-ß (E2) concentration was increased, with a normal testosterone (T) concentration of 0.30 ng/mL. Given the suspicion of the presence of testicular tumors, castration was performed by the surgical excision of both gonads, after ruling out the presence of abdominal or pulmonary metastases by chest and abdominal radiography. Discussion: The clinical, histopathological findings supported the diagnosis of testicular tumors. According to the pathological report, both gonads presented parenchymal nodular neoplastic nodular areas referring to the Sertoli sustentacular cells in the right testicle, to the proliferation of Leydig interstitial cells in the left one. The nodule in the left testicle was unencapsulated and showed a solid-diffuse pattern. Neoplastic cells were irregular polygonal, medium to large in size with moderate nucleus/cytoplasm ratio and moderate anisocytosis. In the right testicle, the nodule was heterogeneous in consistency and a diffuse pattern was present. Neoplastic cells were polygonal morphology, had a moderate nucleus/cytoplasm ratio and were organized tubules lined and obliterated the extensive cell growth. Bilateral orchiectomy allowed to improve the clinical signs, and 3 months after surgery, the animal was in good health, with evident improvement skin lesions. The E2 analysis was repeated, detecting normal values, demonstrating that testicular neoplasm in this patient were involved in E2 production; also T concentration decreased considerably from 0.30 to < 0.07 values.
Assuntos
Animais , Masculino , Cães , Neoplasias Testiculares/veterinária , Tumor de Células de Sertoli-Leydig/veterinária , Células Neoplásicas Circulantes , Orquiectomia/veterináriaResumo
Abstract Letrozole is used as a therapeutic agent in reproductive disorders caused by high estrogen levels. Letrozole inhibits cytochrome P450 aromatase and reduces estrogen levels. However, the effects of long-term use on reproductive traits are unknown. The aim of this study was to evaluate the prolonged use of letrozole in the gonads of rodents (Spix's yellow-toothed cavy; Galea spixii). Forty-eight rodents (24 males and 24 females) were randomly divided into the treated and control groups. Letrozole administration started at 15 days of age and continued weekly until 30, 45, 90, and 120 days of age. The body, testis, and ovary weights were analyzed, as well as the morphological progression of spermatogenesis and folliculogenesis. Macroscopically, body weight gain and gonads weight were increased in the letrozole group. Microscopically, the ovaries of treated females showed stratified epithelium and a cellular disorder of the tunica albuginea. In the testes of treated males, the development of seminiferous tubules was delayed and sperm was absent. The collective findings indicate that the prolonged use of letrozole alters secondary sexual characteristics, and causes weight gain, reproductive changes, and male infertility.
Resumo
The objective of this study was to compare the reproductive efficiency of dairy buffaloes undergoing fixed-time artificial insemination (FTAI) protocols based on progesterone/estrogen (P4/E2) and eCG during unfavorable breeding season using cooled (CS) and frozen semen (FS). A total of 446 buffaloes (> 40 days postpartum) were randomly distributed into four blocks (years): B1-2014 (n = 143), B2-2015 (n = 34), B3-2016 (n = 90), and B4-2017 (n = 179). Each block was subdivided into two (AI with CS and FS using the same ejaculate of each bull). Thus, the block subdivision was as follows: B1 (CS = 71 and FS = 72); B2 (CS = 18 and FS = 16); B3 (CS = 47 and FS = 43); and B4 (CS = 90 and FS = 89). The ejaculates of eight Murrah bulls collected using an artificial vagina were divided into two aliquots: one aliquot was diluted in Botu-Bov® commercial extender and cooled (BB-CS), and the other was diluted in the same extender and frozen (BB-FS). BB-CS aliquots were cooled at 5 °C/24 h using a refrigerator. BB-FS group aliquots were also cooled, and after equilibrating at 5 °C for 4 h, were placed in a 21-L Styrofoam box, 5 cm above the surface of liquid nitrogen. In the afternoon (A) on D0 (2:00 p.m.) the animals received EB 2.0 mg IM (Estrogin®) and an ear implant (CRESTAR® 3.0 mg P4). At D9 (A), the implant was removed, and the animals received eCG 400 IU IM (Folligon® 5000) + Cloprostenol PGF2α 0.530 mg IM (Sincrocio®). At D10 (A), the animals received EB 1.0 mg IM (Estrogin®), and at D12 (8:00 a.m.), AI was performed. At D42, pregnancy was diagnosed via ultrasonography. Total CRs were 48.2% CS and 34.6% FS for years 2014 to 2017, with a significant difference of 13.7% (P<0.05). In conclusion, cooled semen resulted in higher CR than frozen semen in dairy buffaloes under the P4/E2 and eCG FTAI during the unfavorable reproductive season.(AU)
O objetivo deste estudo foi comparar a eficiência reprodutiva de búfalas leiteiras submetidas a protocolos de inseminação artificial em tempo fixo (IATF) à base de progesterona/estrogênio (P4/E2) e eCG, durante a estação reprodutiva desfavorável, usando-se sêmen resfriado (SR) e congelado (SC) Um total de 446 búfalas (> 40 dias após o parto) foi distribuído aleatoriamente em quatro blocos (anos): B1-2014 (n = 143), B2-2015 (n = 34), B3-2016 (n = 90) e B4-2017 (n = 179). Cada bloco foi subdividido em dois (IA com SR e SC utilizando-se a mesma ejaculação de cada touro). Assim, a subdivisão do bloco foi a seguinte: B1 (SR = 71 e SC = 72); B2 (SR = 18 e SC = 16); B3 (SR = 47 e SC = 43); e B4 (SR = 90 e SC = 89). Os ejaculados de oito touros Murrah coletados com vagina artificial foram divididos em duas alíquotas: uma alíquota diluída em diluente comercial Botu-Bov® e resfriada (BB-SR), e a outra diluída no mesmo diluente e congelada (BB-SC). As alíquotas de BB-SR foram resfriados a 5°C/24h usando-se um refrigerador. As alíquotas do grupo BB-SC também foram resfriadas e, após equilíbrio a 5°C por 4h, foram colocadas em uma caixa de isopor de 21L, 5 cm acima da superfície do nitrogênio líquido. À tarde (A), no D0 (14h), os animais receberam BE 2,0 mg IM (Estrogin®) e um implante auricular (Crestar® 3,0 mg P4). No D9 (A), o implante foi retirado e os animais receberam eCG 400 UI IM (Folligon® 5000) + cloprostenol PGF2α 0,530 mg IM (Sincrocio®). No D10 (A), os animais receberam BE 1,0mg IM (Estrogin®), e, no D12 (8h da manhã), foram realizadas as IAs. No D42, a gestação foi diagnosticada por ultrassonografia. As taxas de concepção (TC) totais foram 48,2% SR e 34,6% SC para os anos de 2014 a 2017, com uma diferença significativa de 13,7% (P<0,05). Em conclusão, o sêmen resfriado resultou em maior TC do que o sêmen congelado em bubalinos leiteiros sob P4/E2 e eCG FTAI durante a estação reprodutiva desfavorável.(AU)
Assuntos
Animais , Feminino , Preservação do Sêmen/veterinária , Búfalos/fisiologia , Sincronização do Estro , Progesterona/administração & dosagem , Inseminação Artificial/veterinária , Estrogênios/administração & dosagemResumo
Background: The indiscriminate use of drugs is an issue in Veterinary Medicine, as it has serious consequences for theanimals. Many drugs are myelotoxic and cause a decrease in the production of blood cells, which may be irreversible insome cases. The present work reports a case of pancytopenia induced by the concomitant use of myelotoxic drugs (estrogen, metamizole and phenobarbital) in a dog and describes findings on myelotoxicity, hematological alterations andtreatment success.Case: A 7-year-old Lhasa Apso bitch was referred to the Veterinary Hospital of Federal University of Paraná, Curitibacampus, with hematuria and a history of treatment with phenobarbital [2 mg/kg twice a day (bis in die, BID)], metamizole[25 mg/kg 3 times a day (ter in die, TID)], and use of estrogen hormone (estradiol cypionate). At physical examination, theanimal was normohydrated and exhibited normal palpable lymph nodes, pale mucous membranes, galactorrhea, and a bodytemperature of 36°C. A complete blood count including reticulocyte count and a total plasma protein (TPP) exam wererequested. The results revealed pancytopenia (18% hematocrit, 1,400 total leucocytes/µL, and 22,000 reticulocytes/µL).An abdominal ultrasound exam did not detect any relevant alterations. In view of the results obtained, medullary aplasiawas suspected. A bone marrow aspiration was performed. A myelogram revealed a decrease in cellularity (erythrocyticand granulocytic hypoplasia), with presence of rare erythroid and granulocytic precursors. The diagnosis was medullaryaplasia. The animal was treated, and the evolution of the hematological alterations was monitored. The treatment consistedof administration of erythropoietin (100UI/kg subcutaneously every 48 h), prednisone (2 mg/kg BID), Leucogen (3 mg/kg BID), interferon (0.2 IU/kg BID) and Eritrós Dog Tabs [1 tablet once a day (semel in die, SID)]. After 5 days of treatment, the...
Assuntos
Feminino , Animais , Cães , Cães/sangue , Pancitopenia/veterinária , Anemia Macrocítica/veterinária , Biópsia por Agulha/veterinária , Dipirona/efeitos adversos , Estrogênios/efeitos adversos , Fenobarbital/efeitos adversos , Medula Óssea/patologiaResumo
Background: The indiscriminate use of drugs is an issue in Veterinary Medicine, as it has serious consequences for theanimals. Many drugs are myelotoxic and cause a decrease in the production of blood cells, which may be irreversible insome cases. The present work reports a case of pancytopenia induced by the concomitant use of myelotoxic drugs (estrogen, metamizole and phenobarbital) in a dog and describes findings on myelotoxicity, hematological alterations andtreatment success.Case: A 7-year-old Lhasa Apso bitch was referred to the Veterinary Hospital of Federal University of Paraná, Curitibacampus, with hematuria and a history of treatment with phenobarbital [2 mg/kg twice a day (bis in die, BID)], metamizole[25 mg/kg 3 times a day (ter in die, TID)], and use of estrogen hormone (estradiol cypionate). At physical examination, theanimal was normohydrated and exhibited normal palpable lymph nodes, pale mucous membranes, galactorrhea, and a bodytemperature of 36°C. A complete blood count including reticulocyte count and a total plasma protein (TPP) exam wererequested. The results revealed pancytopenia (18% hematocrit, 1,400 total leucocytes/µL, and 22,000 reticulocytes/µL).An abdominal ultrasound exam did not detect any relevant alterations. In view of the results obtained, medullary aplasiawas suspected. A bone marrow aspiration was performed. A myelogram revealed a decrease in cellularity (erythrocyticand granulocytic hypoplasia), with presence of rare erythroid and granulocytic precursors. The diagnosis was medullaryaplasia. The animal was treated, and the evolution of the hematological alterations was monitored. The treatment consistedof administration of erythropoietin (100UI/kg subcutaneously every 48 h), prednisone (2 mg/kg BID), Leucogen (3 mg/kg BID), interferon (0.2 IU/kg BID) and Eritrós Dog Tabs [1 tablet once a day (semel in die, SID)]. After 5 days of treatment, the...(AU)
Assuntos
Animais , Feminino , Cães , Pancitopenia/veterinária , Cães/sangue , Estrogênios/efeitos adversos , Dipirona/efeitos adversos , Fenobarbital/efeitos adversos , Biópsia por Agulha/veterinária , Medula Óssea/patologia , Anemia Macrocítica/veterináriaResumo
O climatério é uma fase natural da vida da mulher que ocorre entre os 40 e 65 anos de idade e é caracterizado pela transição entre a fase reprodutiva e não reprodutiva. Neste período, devido às alterações hormonais, ocorrem alterações biológicas, endócrinas e clínicas. Sintomas vasomotores são típicos do hipoestrogenismo e podem interferir negativamente na qualidade de vida das mulheres. Este estudo teve como objetivo revisar os resultados dos estudos de intervenção que utilizaram isoflavonas na sintomatologia de mulheres climatéricas não usuárias de Terapia de Reposição Hormonal (TRH). Realizou-se uma revisão sistemática de artigos publicados entre os anos de 2008 e 2019 na base de dados PubMed. Foram encontrados 169 estudos, e considerando os critérios de inclusão, 18 artigos foram selecionados, em que houve intervenção com isoflavonas por meio de cápsulas e/ou suplementos ou alimentos para tratamento da síndrome climatérica. Foram verificados resultados positivos nos sintomas globais, com destaque para sintomas vasomotores, em mais da metade dos estudos avaliados, em que doses entre 45 mg a 160 mg diárias de isoflavonas por pelo menos 12 semanas foram administradas, especificadamente nas mulheres no período da pós-menopausa. (AU)
The climacteric is a natural phase during women's life, which occurs between 40 and 65 years. It is characterized by the transition from their reproductive to non-reproductive phase. In this period, due to hormonal changes, biological, endocrine and clinical modifications also occur. Vasomotor symptoms are characteristic of hypoestrogenism and can negatively affect women's quality of life. This study aimed to review the results of intervention studies which used isoflavones to treat the symptoms of climacteric women who did not undergo Hormone Replacement Therapy (HRT). A systematic review of articles published between 2008 and 2019 in the PubMed database was carried out. 169 studies were found, and considering the inclusion criteria, 18 articles were selected, in which it was described isoflavones intervention with capsules and/ or supplements or foods for the treatment of climacteric syndrome. Positive results were observed regarding to global symptoms, with emphasis on vasomotor symptoms in more than half of the studies, in which daily doses of isoflavones, between 45 mg to 160 mg, for at least 12 weeks, were administered specifically in postmenopausal women. (AU)
Assuntos
Terapias Complementares , Menopausa , Suplementos Nutricionais , Fitoestrógenos , Alimento Funcional , Revisão Sistemática , IsoflavonasResumo
O climatério é uma fase natural da vida da mulher que ocorre entre os 40 e 65 anos de idade e é caracterizado pela transição entre a fase reprodutiva e não reprodutiva. Neste período, devido às alterações hormonais, ocorrem alterações biológicas, endócrinas e clínicas. Sintomas vasomotores são típicos do hipoestrogenismo e podem interferir negativamente na qualidade de vida das mulheres. Este estudo teve como objetivo revisar os resultados dos estudos de intervenção que utilizaram isoflavonas na sintomatologia de mulheres climatéricas não usuárias de Terapia de Reposição Hormonal (TRH). Realizou-se uma revisão sistemática de artigos publicados entre os anos de 2008 e 2019 na base de dados PubMed. Foram encontrados 169 estudos, e considerando os critérios de inclusão, 18 artigos foram selecionados, em que houve intervenção com isoflavonas por meio de cápsulas e/ou suplementos ou alimentos para tratamento da síndrome climatérica. Foram verificados resultados positivos nos sintomas globais, com destaque para sintomas vasomotores, em mais da metade dos estudos avaliados, em que doses entre 45 mg a 160 mg diárias de isoflavonas por pelo menos 12 semanas foram administradas, especificadamente nas mulheres no período da pós-menopausa.(AU)
The climacteric is a natural phase during womens life, which occurs between 40 and 65 years. It is characterized by the transition from their reproductive to non-reproductive phase. In this period, due to hormonal changes, biological, endocrine and clinical modifications also occur. Vasomotor symptoms are characteristic of hypoestrogenism and can negatively affect womens quality of life. This study aimed to review the results of intervention studies which used isoflavones to treat the symptoms of climacteric women who did not undergo Hormone Replacement Therapy (HRT). A systematic review of articles published between 2008 and 2019 in the PubMed database was carried out. 169 studies were found, and considering the inclusion criteria, 18 articles were selected, in which it was described isoflavones intervention with capsules and/ or supplements or foods for the treatment of climacteric syndrome. Positive results were observed regarding to global symptoms, with emphasis on vasomotor symptoms in more than half of the studies, in which daily doses of isoflavones, between 45 mg to 160 mg, for at least 12 weeks, were administered specifically in postmenopausal women.(AU)
Assuntos
Humanos , Feminino , Adulto , Pessoa de Meia-Idade , Isoflavonas/análise , Isoflavonas/uso terapêutico , Climatério/efeitos dos fármacos , Fitoestrógenos/administração & dosagem , Menopausa , Alimento Funcional , Suplementos NutricionaisResumo
Female dogs neutering is a routine surgery that aims to prevent diseases as well as to help populational control. Urinary incontinence is one of the most significant unwanted consequences following the procedure. Pharmacological treatment is recommended for such case, and alpha-adrenergic and estrogenic drugs have been the most frequent choices reported in literature. Besides, tricyclic antidepressants are also able to control clinical signs. The exact mechanism involved with this condition is not yet fully understood. Estrogen deficiency with a subsequent loss of urethral tonus is believed to trigger clinical signs. However, it is possible that other factors such as gonadotropins and gonadotropin-releasing hormone levels may play a part on this complex mechanism of the post-neutering urinary incontinence.(AU)
Assuntos
Animais , Feminino , Cães , Cães/anatomia & histologia , Uretra , Ovariectomia/veterinária , Gonadotropinas , Estrogênios , Incontinência Urinária , EsterilizaçãoResumo
Female dogs neutering is a routine surgery that aims to prevent diseases as well as to help populational control. Urinary incontinence is one of the most significant unwanted consequences following the procedure. Pharmacological treatment is recommended for such case, and alpha-adrenergic and estrogenic drugs have been the most frequent choices reported in literature. Besides, tricyclic antidepressants are also able to control clinical signs. The exact mechanism involved with this condition is not yet fully understood. Estrogen deficiency with a subsequent loss of urethral tonus is believed to trigger clinical signs. However, it is possible that other factors such as gonadotropins and gonadotropin-releasing hormone levels may play a part on this complex mechanism of the post-neutering urinary incontinence.
Assuntos
Feminino , Animais , Cães , Cães/anatomia & histologia , Estrogênios , Gonadotropinas , Incontinência Urinária , Ovariectomia/veterinária , Uretra , EsterilizaçãoResumo
O climatério é uma fase natural da vida da mulher que ocorre entre os 40 e 65 anos de idade e é caracterizado pela transição entre a fase reprodutiva e não reprodutiva. Neste período, devido às alterações hormonais, ocorrem alterações biológicas, endócrinas e clínicas. Sintomas vasomotores são típicos do hipoestrogenismo e podem interferir negativamente na qualidade de vida das mulheres. Este estudo teve como objetivo revisar os resultados dos estudos de intervenção que utilizaram isoflavonas na sintomatologia de mulheres climatéricas não usuárias de Terapia de Reposição Hormonal (TRH). Realizou-se uma revisão sistemática de artigos publicados entre os anos de 2008 e 2019 na base de dados PubMed. Foram encontrados 169 estudos, e considerando os critérios de inclusão, 18 artigos foram selecionados, em que houve intervenção com isoflavonas por meio de cápsulas e/ou suplementos ou alimentos para tratamento da síndrome climatérica. Foram verificados resultados positivos nos sintomas globais, com destaque para sintomas vasomotores, em mais da metade dos estudos avaliados, em que doses entre 45 mg a 160 mg diárias de isoflavonas por pelo menos 12 semanas foram administradas, especificadamente nas mulheres no período da pós-menopausa.
The climacteric is a natural phase during womens life, which occurs between 40 and 65 years. It is characterized by the transition from their reproductive to non-reproductive phase. In this period, due to hormonal changes, biological, endocrine and clinical modifications also occur. Vasomotor symptoms are characteristic of hypoestrogenism and can negatively affect womens quality of life. This study aimed to review the results of intervention studies which used isoflavones to treat the symptoms of climacteric women who did not undergo Hormone Replacement Therapy (HRT). A systematic review of articles published between 2008 and 2019 in the PubMed database was carried out. 169 studies were found, and considering the inclusion criteria, 18 articles were selected, in which it was described isoflavones intervention with capsules and/ or supplements or foods for the treatment of climacteric syndrome. Positive results were observed regarding to global symptoms, with emphasis on vasomotor symptoms in more than half of the studies, in which daily doses of isoflavones, between 45 mg to 160 mg, for at least 12 weeks, were administered specifically in postmenopausal women.
Assuntos
Feminino , Humanos , Adulto , Pessoa de Meia-Idade , Climatério/efeitos dos fármacos , Fitoestrógenos/administração & dosagem , Isoflavonas/análise , Isoflavonas/uso terapêutico , Menopausa , Alimento Funcional , Suplementos NutricionaisResumo
Letrozole is used as a therapeutic agent in reproductive disorders caused by high estrogen levels. Letrozole inhibits cytochrome P450 aromatase and reduces estrogen levels. However, the effects of longterm use on reproductive traits are unknown. The aim of this study was to evaluate the prolonged use of letrozole in the gonads of rodents (Spix's yellow-toothed cavy; Galea spixii). Forty-eight rodents (24 males and 24 females) were randomly divided into the treated and control groups. Letrozole administration started at 15 days of age and continued weekly until 30, 45, 90, and 120 days of age. The body, testis, and ovary weights were analyzed, as well as the morphological progression of spermatogenesis and folliculogenesis. Macroscopically, body weight gain and gonads weight were increased in the letrozole group. Microscopically, the ovaries of treated females showed stratified epithelium and a cellular disorder of the tunica albuginea. In the testes of treated males, the development of seminiferous tubules was delayed and sperm was absent. The collective findings indicate that the prolonged use of letrozole alters secondary sexual characteristics, and causes weight gain, reproductive changes, and male infertility.(AU)
Assuntos
Animais , Roedores/anatomia & histologia , Roedores/fisiologia , Gônadas , Letrozol/administração & dosagem , Letrozol/análise , Comportamento ReprodutivoResumo
The present study investigated the male effect on the estrus behaviors, estradiol and progesterone release in prepubertal Saanen goats. Twenty-nine female Saanen goats at 135 ± 10 days old with body weight of 22.8 ± 3.3 Kg were randomly assigned to three treatments: exposure to sexually active male (male treatment), exposure to androgenized females (androgenized female treatment), and prepubertal goats isolated from active male and androgenized females (control treatment). Sexual behaviors associated with estrus were recorded daily, and blood samples were taken weekly to determine estradiol and progesterone concentrations over 24 weeks. The experimental goats subjected to male or androgenized female had significantly higher frequency of estrus (mount acceptance) (P ≤ 0,02), progesterone (P ≤ 0,01), and estradiol (P ≤ 0,01) release than the control goats. Furthermore, goats exposed to a male showed estrus behavior two weeks earlier and maintained this estrus behavior for three weeks more than goats of both female and control treatments. Estrus was observed in 70 % of goats in male and female treatments during the breeding season versus 44 % of the control goats. Finally, significantly more goats subjected to male treatment (60 % of goats) showed progesterone concentrations higher than 1 ng mL-1 (which indicates the presence of a functional corpus luteum) compared to the female and control treatment (40 and 22 % of goats, respectively). These results shows that male treatment significantly increased the number of females showing estrus behavior, estradiol and progesterone release, and the number of animals with a functional corpus luteum, anticipating puberty for experimental goats, suggesting that the male effect could be used to anticipate the onset of puberty in goats.(AU)
O presente estudo investigou o efeito do macho sobre o comportamento do estro, liberação de estradiol e progesterona em cabritas Sannen pré-púberes. Vinte e nove cabritas com 135 ± 10 dias de idade e peso corporal de 22,8 ± 3,3 kg foram submetidas à três tratamentos: macho; fêmeas androgenizadas; controle (mantidas isoladas do efeito macho ou de fêmeas androgenizadas) . Os comportamentos sexuais foram registrados diariamente e as amostras de sangue foram colhidas semanalmente ao longo de 24 semanas. Os tratamentos macho e fêmea androgenizada aumentaram significativamente a ocorrência comportamental do estro (P ≤ 0,02), a concentração de progesterona (P ≤ 0,01) e estradiol (P ≤ 0,01) em comparação ao tratamento controle. As cabritas expostas ao efeito macho anteciparam o comportamento de estro em duas semanas, e o mantiveram por mais três semanas quando comparado às cabritas dos tratamentos fêmea androgenizada e controle. Apenas 44% das cabritas controle foram observadas em estro, sendo que 70% das cabritas submetidas aos tratamentos macho e fêmea androgenizada foram observadas em estro. Além disso, 60% das cabritas expostas ao efeito macho, 40 % das cabritas expostas ao efeito fêmea androgenizada e 22% das cabritas controle apresentaram concentrações de progesterona superiores a 1 ng mL-1, o que indica a presença de corpo lúteo funcional. De fato, o efeito macho aumentou significativamente o número de fêmeas em estro, a concentração de estradiol e progesterona, o número de fêmeas com corpo lúteo funcional, sugerindo que o efeito macho pode ser usado para antecipar o início da puberdade em cabritas Saanen.(AU)
Assuntos
Animais , Masculino , Feminino , Comportamento Sexual Animal/fisiologia , Maturidade Sexual/fisiologia , Estro/fisiologia , Cabras/fisiologia , Progesterona/biossíntese , Corpo Lúteo/citologia , Estrogênios/biossínteseResumo
A eficiência reprodutiva na bovinocultura é essencial para a produtividade e lucratividade do sistema. O ambiente uterino tem importância fundamental para o estabelecimento e manutenção da gestação em diferentes espécies e pode ser influenciado pela ação de diversos hormônios. Sabe-se que as concentrações fisiológicas de estrógeno possuem efeito sobre a imunidade, estrutura e funcionalidade uterina. Alguns autores utilizaram administrações de estrógeno, em doses isoladas, como profilaxia ou terapia em casos de infertilidade, entretanto, não foram observados efeitos benéficos ou até mesmo houve um aumento da contaminação bacteriana. Porém, outros estudos que utilizaram repetidas doses de estrógeno demonstraram efeitos positivos no desempenho reprodutivo em vacas repetidoras. Ainda, protocolos de inseminação artificial em tempo fixo (IATF) com suplementação de estrógeno ou com período prolongado de proestro têm possibilitado maiores taxas de prenhez e menos perdas gestacionais. Com base nisso, se faz necessário a realização de pesquisas que abordem o efeito do estrógeno sobre a fertilidade em condições controladas. O objetivo desta revisão é discutir aspectos relacionados a exposição ao estrógeno para prevenção ou terapia de transtornos reprodutivos com foco no ambiente uterino.(AU)
Reproductive efficiency in cattle is essential for the productivity and profitability of the system. The uterine environment has a fundamental importance for pregnancy establishment and maintenance in different species and can be influenced by the action of several hormones. It is well established that physiological concentrations of estrogen have effect on the uterine immunity, structure and functionality. Some authors evaluated estrogen administration, in single doses, for prophylaxis or therapy of infertility; however, no beneficial effects were observed, and, in some cases, there was an increase in bacterial contamination. Conversely, other studies using repeated doses of estrogen demonstrated positive effects on reproductive performance in repeat breeder cows. Furthermore, timedartificial insemination (TAI) protocols using estrogen or with prolonged proestrus are associated with increased pregnancy rates and seem to prevent pregnancy losses. Based on this, it is necessary to perform studies evaluating the effect of estrogen on fertility under controlled conditions. The objective of this review is to discuss aspects related to the exposure to estrogens to prevent or overcome reproductive disorders focusing on the uterine environment.(AU)
Assuntos
Animais , Feminino , Bovinos , Estrogênios/análogos & derivados , Estrogênios/análiseResumo
A eficiência reprodutiva na bovinocultura é essencial para a produtividade e lucratividade do sistema. O ambiente uterino tem importância fundamental para o estabelecimento e manutenção da gestação em diferentes espécies e pode ser influenciado pela ação de diversos hormônios. Sabe-se que as concentrações fisiológicas de estrógeno possuem efeito sobre a imunidade, estrutura e funcionalidade uterina. Alguns autores utilizaram administrações de estrógeno, em doses isoladas, como profilaxia ou terapia em casos de infertilidade, entretanto, não foram observados efeitos benéficos ou até mesmo houve um aumento da contaminação bacteriana. Porém, outros estudos que utilizaram repetidas doses de estrógeno demonstraram efeitos positivos no desempenho reprodutivo em vacas repetidoras. Ainda, protocolos de inseminação artificial em tempo fixo (IATF) com suplementação de estrógeno ou com período prolongado de proestro têm possibilitado maiores taxas de prenhez e menos perdas gestacionais. Com base nisso, se faz necessário a realização de pesquisas que abordem o efeito do estrógeno sobre a fertilidade em condições controladas. O objetivo desta revisão é discutir aspectos relacionados a exposição ao estrógeno para prevenção ou terapia de transtornos reprodutivos com foco no ambiente uterino.
Reproductive efficiency in cattle is essential for the productivity and profitability of the system. The uterine environment has a fundamental importance for pregnancy establishment and maintenance in different species and can be influenced by the action of several hormones. It is well established that physiological concentrations of estrogen have effect on the uterine immunity, structure and functionality. Some authors evaluated estrogen administration, in single doses, for prophylaxis or therapy of infertility; however, no beneficial effects were observed, and, in some cases, there was an increase in bacterial contamination. Conversely, other studies using repeated doses of estrogen demonstrated positive effects on reproductive performance in repeat breeder cows. Furthermore, timedartificial insemination (TAI) protocols using estrogen or with prolonged proestrus are associated with increased pregnancy rates and seem to prevent pregnancy losses. Based on this, it is necessary to perform studies evaluating the effect of estrogen on fertility under controlled conditions. The objective of this review is to discuss aspects related to the exposure to estrogens to prevent or overcome reproductive disorders focusing on the uterine environment.
Assuntos
Feminino , Animais , Bovinos , Estrogênios/análise , Estrogênios/análogos & derivadosResumo
As complicações gestacionais em éguas, em especial no terço final da gestação, representam um grande problema para a indústria equina, podendo acarretar em consequências maternas, fetais e em implicações no próprio potro neonato. A garantia de uma gestação adequada abrange as trocas metabólicas entre o potro e a égua, e a manutenção do adequado ambiente intra-uterino para o desenvolvimento fetal. Assim, objetivo do presente é apresentar métodos de monitoramento de éguas gestantes, com ênfase nas gestações de risco, buscando o nascimento de um potro saudável. Os procedimentos iniciam pela avaliação do histórico e exame regular das éguas. Essa conduta consiste no exame clínico obstétrico, ultrassonografia transretal e transabdominal. Além da avaliação de alguns biomarcadores séricos, ainda que controversos na literatura, como a dosagem de progesterona, estrógenos (estrógenos totais e/ou 17β- estradiol), amiloide A sérica e alfa-feto proteína quando disponíveis.(AU)
Complications in pregnant mares, especially in late gestation, remains a major cause of economic loss for horse breeders. Those could lead maternal, fetal and neonatal implications. Healthy intrauterine environment and on placental efficiency are essential for fetal development. Therefore, the aim of this review is described methods of monitoring pregnant mares to seek a healthy neonatal foal, particularly in a high-risk pregnancy. The first step is the collection of medical histories and systematic clinical examination of the mares. This regular examination realizes clinical obstetric evaluation, transrectal and transabdominal ultrasound exam. In addition to peripheral blood markers assessment, although sometimes controversial, as progesterone, estrogens (total estrogen and/or 17βestradiol), serum amyloide A and alpha-fetoprotein when available.(AU)
Assuntos
Animais , Feminino , Cavalos/embriologia , Cavalos/fisiologia , Gravidez de Alto Risco , FetoResumo
As complicações gestacionais em éguas, em especial no terço final da gestação, representam um grande problema para a indústria equina, podendo acarretar em consequências maternas, fetais e em implicações no próprio potro neonato. A garantia de uma gestação adequada abrange as trocas metabólicas entre o potro e a égua, e a manutenção do adequado ambiente intra-uterino para o desenvolvimento fetal. Assim, objetivo do presente é apresentar métodos de monitoramento de éguas gestantes, com ênfase nas gestações de risco, buscando o nascimento de um potro saudável. Os procedimentos iniciam pela avaliação do histórico e exame regular das éguas. Essa conduta consiste no exame clínico obstétrico, ultrassonografia transretal e transabdominal. Além da avaliação de alguns biomarcadores séricos, ainda que controversos na literatura, como a dosagem de progesterona, estrógenos (estrógenos totais e/ou 17β- estradiol), amiloide A sérica e alfa-feto proteína quando disponíveis.
Complications in pregnant mares, especially in late gestation, remains a major cause of economic loss for horse breeders. Those could lead maternal, fetal and neonatal implications. Healthy intrauterine environment and on placental efficiency are essential for fetal development. Therefore, the aim of this review is described methods of monitoring pregnant mares to seek a healthy neonatal foal, particularly in a high-risk pregnancy. The first step is the collection of medical histories and systematic clinical examination of the mares. This regular examination realizes clinical obstetric evaluation, transrectal and transabdominal ultrasound exam. In addition to peripheral blood markers assessment, although sometimes controversial, as progesterone, estrogens (total estrogen and/or 17βestradiol), serum amyloide A and alpha-fetoprotein when available.
Assuntos
Feminino , Animais , Cavalos/embriologia , Cavalos/fisiologia , Feto , Gravidez de Alto RiscoResumo
Background: Demyelination refers to the degradation or loss of myelin sheath. In demyelination model studies, it has been reported that demyelination is regressed by giving steroid hormones such as estrogen and progesterone. However, there are not many studies investigating the synthesis of these two hormones by the brain during demyelination and remyelination. Neurosteroids are steroid hormones synthesized by the brain independently from peripheral tissues. In this study, it was aimed to have knowledge about the synthesis of these two hormones by the brain in experimentally formed demyelination process in brains of C57BL/6 mice and their role in the cellular response formed in the region.Materials, Methods & Results: In the study, 36 C57BL/6 mice were used: 12 mice were fed normal diet for 12 weeks as control group (Group I); 12 of them were fed 0.2% cuprizone diet for 8 weeks (Group II) and 12 mice were fed normal diet for 4 weeks after feeding cuprizone diet for 8 weeks (Group III). At the end of the experiment, mice were perfused with 4% paraformaldehyde and brain tissues were blocked in paraffin. 6 μm-thick section was taken from each block. Sections were stained histologically with LFB staining and immunohistochemically with MBP staining in order to determine the demyelination in sections. All sections were also immunohistochemically stained with GFAP to detect astrocytes, with NG2 to detect young OPCs, with aromatase for estrogen synthesis and with 3βHSD antibodies for progesterone synthesis. At the end of the study, complete myelination was observed in group I, while severe demyelination was determined in group II as a result of blind evaluation of LFB and MBP staining by two pathologists. In group III, demyelination was found to be mild. In immunostaining with GFAP and NG2 antibodies, the number of GFAP and NG2 positive cells in Group II was found to be increased compared to the control group.[...]
Assuntos
Masculino , Animais , Camundongos , Doenças Desmielinizantes/induzido quimicamente , Doenças Desmielinizantes/terapia , Estrogênios/agonistas , Estrogênios/síntese química , Progesterona/agonistas , Progesterona/síntese química , Aromatase , Cuprizona/efeitos adversos , Modelos Animais de Doenças , Progesterona RedutaseResumo
Background: Demyelination refers to the degradation or loss of myelin sheath. In demyelination model studies, it has been reported that demyelination is regressed by giving steroid hormones such as estrogen and progesterone. However, there are not many studies investigating the synthesis of these two hormones by the brain during demyelination and remyelination. Neurosteroids are steroid hormones synthesized by the brain independently from peripheral tissues. In this study, it was aimed to have knowledge about the synthesis of these two hormones by the brain in experimentally formed demyelination process in brains of C57BL/6 mice and their role in the cellular response formed in the region.Materials, Methods & Results: In the study, 36 C57BL/6 mice were used: 12 mice were fed normal diet for 12 weeks as control group (Group I); 12 of them were fed 0.2% cuprizone diet for 8 weeks (Group II) and 12 mice were fed normal diet for 4 weeks after feeding cuprizone diet for 8 weeks (Group III). At the end of the experiment, mice were perfused with 4% paraformaldehyde and brain tissues were blocked in paraffin. 6 μm-thick section was taken from each block. Sections were stained histologically with LFB staining and immunohistochemically with MBP staining in order to determine the demyelination in sections. All sections were also immunohistochemically stained with GFAP to detect astrocytes, with NG2 to detect young OPCs, with aromatase for estrogen synthesis and with 3βHSD antibodies for progesterone synthesis. At the end of the study, complete myelination was observed in group I, while severe demyelination was determined in group II as a result of blind evaluation of LFB and MBP staining by two pathologists. In group III, demyelination was found to be mild. In immunostaining with GFAP and NG2 antibodies, the number of GFAP and NG2 positive cells in Group II was found to be increased compared to the control group.[...](AU)
Assuntos
Animais , Masculino , Camundongos , Estrogênios/agonistas , Estrogênios/síntese química , Progesterona/agonistas , Progesterona/síntese química , Doenças Desmielinizantes/induzido quimicamente , Doenças Desmielinizantes/terapia , Modelos Animais de Doenças , Cuprizona/efeitos adversos , Aromatase , Progesterona RedutaseResumo
O objetivo desse estudo foi avaliar as concentrações séricas de estradiol, progesterona e prolactina, bem como a expressão gênica dos receptores de estrógeno α e β e de progesterona em cadelas com neoplasias mamárias. Foram utilizadas 60 cadelas adultas, sem raça definida que foram distribuídas em dois grupos. O Grupo I constituído por 30 cadelas portadoras de neoplasias mamárias e o Grupo II constituído por 30 cadelas saudáveis, não portadoras de neoplasia. Para os tutores, foram aplicados questionários sobre fatores epidemiológicos da doença. Após avaliação dos exames pré-operatórios, as cadelas com neoplasia mamária foram submetidas à mastectomia, coletaram-se fragmentos das neoplasias e linfonodos regionais, os quais foram processados para análise histopatológica. Para as dosagens hormonais de estradiol, progesterona e prolactina foram colhidas amostras de sangue em tubos sem anticoagulante e os soros foram submetidos à técnica de eletroquimioluminescência. A expressão gênica dos receptores hormonais foi realizada por meio da técnica de Real-time PCR e para isso foram coletados fragmentos das neoplasias mamárias e extraído o RNA para obtenção do cDNA. A expressão do mRNA para os REα, REβ e RP foi avaliada a partir da amplificação desses genes utilizando primers específicos. Verificaram-se maiores níveis séricos de estradiol (média de 38,98±13,68pg/mL) em cadelas portadoras de neoplasias mamárias malignas quando comparadas as cadelas do grupo controle (p<0,05). Já os níveis séricos de prolactina foram maiores (média de 0,231±0,201ng/mL) nas cadelas que não possuíam neoplasias mamárias quando comparadas ao Grupo I (p<0,05). Para os níveis de progesterona não foram observadas diferença entre os diferentes grupos (p>0,05). Tanto os tumores malignos como os benignos expressaram REα, REβ e RP, não havendo diferença (p>0,05) na expressão...(AU)
The aim of this study was to evaluate the serum concentrations of estradiol, progesterone, prolactin, the gene expression of estrogen α and β and progesterone receptors in bitches with mammary neoplasms. Sixty adult crossbred bitches distributed in two groups were used. Group I consisted of 30 bitches with mammary neoplasms and Group II consisted of 30 healthy bitches without neoplasia. For the tutors, interviews were made about the disease epidemiology. After preoperative examinations, bitches with mammary neoplasia were submitted to mastectomy; fragments of the neoplasms and regional lymph nodes were collected and processed for histopathological analysis. Blood samples were collected in tubes without anticoagulant and the serum was analyzed by electrochemiluminescence to measure estradiol, progesterone and prolactin. The gene expression of the hormonal receptors was performed by means of the Real-time PCR technique, thus fragments of mammary neoplasms were collected and the RNA was extracted to obtain cDNA. Expression of the mRNA for ERα, ERβ and PR was assessed from the amplification of these genes using specific primers. Higher serum levels of estradiol (mean 38.98±13.68pg/mL) were observed in bitches with malignant neoplasms when compared to the control bitches (p<0.05). Serum prolactin levels were higher (mean of 0.231±0.201ng/mL) in bitches that did not have mammary neoplasms when compared to Group I (p<0.05). No difference was observed for related to the progesterone levels between the groups (p>0.05). Both malignant and benign tumors expressed ERα, ERβ and RP with no statistical difference (p>0.05) and there were no difference related to the other prognostic factors investigated (clinical staging, presence of ulceration, vascularization and aging of neoplasms). Serum estradiol levels increased significantly with the clinical staging of the...(AU)